MAPT and Alzheimer disease: In these mice, exogenous tau ‘seeds’ in the form of recombinant fibrils or tau-enriched brain fractions derived from tau transgenic mouse or AD brain are locally injected into a specific brain region, and the progressive spread of tau pathology into anatomically connected brain regions is observed30–37.